Voices of Children and Adolescents on Phase 1 or Phase 2 Cancer Trials: A New Trial Endpoint?

Authors

Pamela S Hinds, George Washington UniversityFollow
Jichuan Wang, George Washington University
Emily Dunn Stern
Catherine Fiona Macpherson
Claire M Wharton
Ruthanna Okorosobo, George Washington University
Yao Iris Cheng
Heather E Gross
Holly J MeanyFollow
Shana Jacobs, George Washington University

Document Type

Journal Article

Publication Date

10-1-2017

Journal

Cancer

Volume

123

Issue

19

DOI

10.1002/cncr.30782

Keywords

Adolescent; Antineoplastic Agents; Child; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Family; Fatigue; Feasibility Studies; Female; Humans; Longitudinal Studies; Male; Mobility Limitation; Neoplasms; Patient Reported Outcome Measures; Quality of Life; Reproducibility of Results; Surveys and Questionnaires; Symptom Assessment

APA Citation

Hinds, P., Wang, J., Stern, E., Macpherson, C., Wharton, C., Okorosobo, R., Cheng, Y., Gross, H., Meany, H., & Jacobs, S. (2017). Voices of Children and Adolescents on Phase 1 or Phase 2 Cancer Trials: A New Trial Endpoint?. Cancer, 123 (19). http://dx.doi.org/10.1002/cncr.30782

Peer Reviewed

1